ELTX
Elicio Therapeutics
$1.75
−$0.10 (−5.41%)Oct 29, 2026
Key metrics
The numbers that frame ELTX today
- Market cap
- $45.99M
- ROIC
- -252%
- Div yield
- 0%
- Debt / equity
- 1.8
- 52wk Low
- $1.44
- 52wk High
- $16.00
Growth
Revenue and earnings trend for ELTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ELTX
Is Elicio Therapeutics a good buy?
No. Elicio Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Elicio Therapeutics is selling at a very high price.
What is the market capitalization of ELTX?
Elicio Therapeutics's market capitalization is $45.99M.
What is the 52-week high for ELTX stock?
The 52-week high for Elicio Therapeutics is $16.00. The current close of $1.75 is 89.1% below that high.
What is the 52-week low for ELTX stock?
The 52-week low for Elicio Therapeutics is $1.44. The current close of $1.75 is 21.5% above that low.
Does ELTX stock pay dividends?
Elicio Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ELTX?
Elicio Therapeutics's Debt / Equity ratio is 1.78.